135 related articles for article (PubMed ID: 37653807)
1. Meta-analysis of the efficacy and safety of Xihuang Pills/capsules in adjuvant treatment of uterine cervical neoplasms.
Xu H; Tian G; Wu C; Sun X; Li K
Medicine (Baltimore); 2023 Aug; 102(34):e34846. PubMed ID: 37653807
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of Xihuang Pill/capsule in adjuvant treatment of breast cancer: A systematic review and meta-analysis of 26 randomized controlled trials.
Ge A; Yang K; Deng X; Zhao D; Ge J; Liu L
J Ethnopharmacol; 2022 Sep; 295():115357. PubMed ID: 35545184
[TBL] [Abstract][Full Text] [Related]
3. The prospect of
Chen Z; Li Z; Yang S; Wei Y; An J
Heliyon; 2023 Apr; 9(4):e15490. PubMed ID: 37128341
[TBL] [Abstract][Full Text] [Related]
4. [Network Meta-analysis of oral Chinese patent medicine for adjuvant treatment of primary liver cancer].
Zhang RR; Shao MY; Fu Y; Zhao RX; Wang JW; Li M; Zhao YX; Shao FL
Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2333-2343. PubMed ID: 34047138
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of Xihuang pills' intervention in the tumour immune microenvironment for the treatment of liver cancer based on the STAT3-PDL1 pathway.
Wang Y; Wang W; Liu K; Liu Y; Shen X; Li Q; Deng F; Hao X; Wang Y
J Ethnopharmacol; 2024 May; 331():118278. PubMed ID: 38710457
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of Shouhui Tongbian Capsules in the treatment of constipation: A systematic review and meta-analysis.
Guo X; Li R; Huang N; Zhang T; Li J; Gong L; Sun R
Phytomedicine; 2023 Jan; 108():154541. PubMed ID: 36375236
[TBL] [Abstract][Full Text] [Related]
8. [Network Meta-analysis of six Chinese patent medicines for replenishing Qi and activating blood in treatment of chronic heart failure].
Park YS; Wang W; Li YD; Liu K
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4221-4237. PubMed ID: 36046913
[TBL] [Abstract][Full Text] [Related]
9. [Systematic review and Meta-analysis of efficacy and safety of Ningmitai Capsules in treatment of urinary tract infection].
Wang ZQ; Lyu J; Li JB; Xie YM
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3648-3657. PubMed ID: 35850819
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Aspirin With Combined Compound Danshen Dropping Pills on Hemorheology and Blood Lipids in Middle-Aged and Elderly Patients With CHD: A Systematic Review and Meta-Analysis.
Liu Z; Li G; Ma Y; Lin L
Front Public Health; 2021; 9():664841. PubMed ID: 34222174
[No Abstract] [Full Text] [Related]
11. [Network Meta-analysis of Chinese patent medicine in treatment of unstable angina pectoris].
Zhang LM; DU TH; Niu LL; Wang LY; Li JN; Ma PF; Yu R
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):703-711. PubMed ID: 33645038
[TBL] [Abstract][Full Text] [Related]
12. [Shensong Yangxin Capsules in the adjuvant treatment of stable angina pectoris:a Meta-analysis and trial sequential analysis].
Xi YT; Yuan LY; Zeng YY; Yan ML; Liang XR; Feng AT; Wu W
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3816-3824. PubMed ID: 31602958
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal medicine for oesophageal cancer.
Chen X; Deng L; Jiang X; Wu T
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004520. PubMed ID: 26799001
[TBL] [Abstract][Full Text] [Related]
14. [Systematic evaluation of Huaier Granules adjuvant treatment of primary liver cancer].
Zhang RR; Shao MY; Fu Y; Zhao RX; Wang JW; Li M; Zhao YX; Shao FL
Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(2):478-487. PubMed ID: 33645137
[TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis of Xihuang Pill Efficacy When Combined with Chemotherapy for Treatment of Breast Cancer.
Mao D; Feng L; Huang S; Zhang S; Peng W; Zhang S
Evid Based Complement Alternat Med; 2019; 2019():3502460. PubMed ID: 30992708
[TBL] [Abstract][Full Text] [Related]
16. [Effect and mechanism of Xihuang Pills on rats with precancerous lesions of breast].
Zhang YJ; Huang PW; Zhang YT; Wang Z; Feng NP
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3546-3555. PubMed ID: 37474988
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety of NSCLC ancillary treatment with compound Kushen injection through immunocompetence regulation: A systematic review and meta-analysis.
Wang D; Xu Y; Huang T; Peng W; Zhu D; Zhou X; Wu Q
Phytomedicine; 2022 Sep; 104():154315. PubMed ID: 35868145
[TBL] [Abstract][Full Text] [Related]
18. [Network Meta-analysis of Chinese patent medicines in treatment of liver stagnation and spleen deficiency of depression].
Yu Y; Zhang G; Han T; Li J; Huang HL
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(23):5217-5224. PubMed ID: 32237360
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of anti-hyperplasia of mammary glands of Xihuang Pills blood-entering component based on UPLC-Q-TOF-MS and network pharmacology].
Fan QR; Chen M; Dong XY; Tao R; Wang JR; Xia SL; Lan YM; Han T
Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6749-6764. PubMed ID: 38212035
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of Gushen Antai Pills combined with dydrogesterone in the treatment of threatened miscarriage: a systematic review and meta-analysis.
Chen K; Liu X; Meng X; Li H; Yang C; Wang X
Front Pharmacol; 2023; 14():1138968. PubMed ID: 37332346
[No Abstract] [Full Text] [Related]
[Next] [New Search]
